In this regards, our meta-analysis from a public clinical microarray database of both ovarian cancer patients and breast cancer patients undergone chemotherapy, which contained cisplatin36, 37, revealed that lower levels of WEE1 correlates with longer relapse free period of time. Here, WEE1 is linked to ovarian carcinoma.